Correlation Between Horizon Space and Acrivon Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Horizon Space and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Horizon Space and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Horizon Space Acquisition and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Horizon Space and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Horizon Space with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Horizon Space and Acrivon Therapeutics,.

Diversification Opportunities for Horizon Space and Acrivon Therapeutics,

-0.36

Correlation Coefficient

Horizon Space  Acrivon Therapeutics,

Very good diversification

The 3 months correlation between Horizon and Acrivon is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Horizon Space Acquisition and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Horizon Space is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Horizon Space Acquisition are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Horizon Space i.e., Horizon Space and Acrivon Therapeutics, go up and down completely randomly.

Pair Corralation between Horizon Space and Acrivon Therapeutics,

Assuming the 90 days horizon Horizon Space Acquisition is expected to generate 0.25 times more return on investment than Acrivon Therapeutics,. However, Horizon Space Acquisition is 4.08 times less risky than Acrivon Therapeutics,. It trades about 0.04 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about -0.07 per unit of risk. If you would invest  1,137  in Horizon Space Acquisition on December 2, 2024 and sell it today you would earn a total of  34.00  from holding Horizon Space Acquisition or generate 2.99% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Horizon Space Acquisition  vs.  Acrivon Therapeutics, Common

Horizon Space Acquisition

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Horizon Space Acquisition are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Horizon Space is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Acrivon Therapeutics,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Acrivon Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in April 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Horizon Space and Acrivon Therapeutics,

The main advantage of trading using opposite Horizon Space and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Horizon Space position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.

The idea behind Horizon Space Acquisition and Acrivon Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..